Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

May 2026A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

City of Hope Medical Center — PHASE1

TrialRECRUITING

Feb 2026Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

University of Arizona — PHASE1

TrialNOT YET RECRUITING

Sep 2025Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Federal Research Institute of Pediatric Hematology, Oncology and Immunology — PHASE2, PHASE3

TrialRECRUITING

Aug 2025To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Peking University People's Hospital — PHASE1

TrialRECRUITING

Jul 2025A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Center for International Blood and Marrow Transplant Research — PHASE2

TrialRECRUITING

May 2025Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Vastra Gotaland Region — PHASE2

TrialRECRUITING

May 2025Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

Peking University First Hospital

TrialRECRUITING

Apr 2025Mosaic Trial for Stem Cell Transplant Recipients

Northwestern University — NA

TrialRECRUITING

Jan 2025Massage Impact on Sleep in Pediatric Oncology

Children's Hospital of Philadelphia — NA

TrialRECRUITING

Jan 2025Allo-HSCT vs ASCT in Adult T-LBL

Peking University People's Hospital — NA

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement.
Check the disease page for updates →

Clinical Trial Landscape

14 active trials

1Phase 3

3Phase 2

3Phase 1

2N/A

2Unknown

2PHASE1, PHASE2

1EARLY_PHASE1

14Total recruiting

Search clinical trials for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement →

Recent News & Research

No recent news articles indexed yet for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement.
Search PubMed for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement →

Browse all Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement news →

Specialist Network

Top 6 by expertise

Zachariah DeFilipp, MD, M.D

Masachusetts General Hospital

📍 ATLANTA, GA

Score 375 trials

Rachel B. Salit, MD

Fred Hutch/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 374 trials

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 2917 trials

Farid Boulad, MD, MD

Memorial Sloan Kettering Cancer Center

📍 NEW YORK, NY

Score 277 trials

Minocher Battiwalla, MD, MD

National Institutes of Health- NHLBI

📍 NASHVILLE, TN

Score 262 trials

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Score 2111 trials

View all Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰